Skip to main content

CORRECTION article

Front. Pharmacol., 30 October 2020
Sec. Predictive Toxicology
Volume 11 - 2020 | https://doi.org/10.3389/fphar.2020.594471

Corrigendum: The Role of S1P and the Related Signaling Pathway in the Development of Tissue Fibrosis

This article is a correction to:

  1. The Role of S1P and the Related Signaling Pathway in the Development of Tissue Fibrosis

    1. Read original article
Erjin WangErjin Wang1Xingxuan HeXingxuan He2Ming Zeng*Ming Zeng1*
  • 1Department of Health Toxicology, Xiangya School of Public Health, Central South University, Changsha, China
  • 2Department of Human Genetics and Genomic Sciences, Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, NY, United States

A Corrigendum on
The Role of S1P and the Related Signaling Pathway in the Development of Tissue Fibrosis

By: Wang E, He X and Zeng M (2019) Front. Pharmacol. 9:1504. doi: 10.3389/fphar.2018.01504

In the original article, the reference for “Borel et al., 2010” was incorrectly written as “Borel, J. F., Feurer, C., Hiestand, P. C., and Stähelin, H. (2010). Transforming growth factor-beta1 induces transdifferentiation of myoblasts into myofibroblasts via up-regulation of sphingosine kinase-1/S1P3 axis. Mol. Biol. Cell 21, 1111–1124. doi: 10.1091/mbc.E09-09-0812.” It should be “Cencetti, F., Bernacchioni, C., Nincheri, P., Donati, C., and Bruni, P. (2010). Transforming growth factor-beta1 induces transdifferentiation of myoblasts into myofibroblasts via up-regulation of sphingosine kinase-1/S1P3 axis. Mol. Biol. Cell 21, 1111–1124. doi: 10.1091/mbc.E09-09-0812.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Keywords: sphingosine 1-phosphate, tissue fibrosis, SphK, S1PRs, clinical treatment

Citation: Wang E, He X and Zeng M (2020) Corrigendum: The Role of S1P and the Related Signaling Pathway in the Development of Tissue Fibrosis. Front. Pharmacol. 11:594471. doi: 10.3389/fphar.2020.594471

Received: 13 August 2020; Accepted: 14 August 2020;
Published: 30 October 2020.

Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2020 Wang, He and Zeng. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Ming Zeng, zengming@csu.edu.cn

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.